US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

693.03

+4.110.60%

Number of Gainers:71

Number of Losers:69

Number of Flat:14

PE:- -

High:698.21

Open:689.82

Low:685.07

Close:688.92

Volume:272.16M

Turnover:8.90B

Market Cap:479.85B

Float Cap:365.12B

Loading ...

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Biomea Fusion to Participate in Upcoming Investor Conferences

Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference

Climb Bio Reports Early Phase 1 Data for IgA Nephropathy Drug

MT Newswires Live

Clean Sweep or Split Congress, These are the Trades to Make on the Midterms Outcome, Says JPMorgan

Climb Bio - Announces Positive Phase 1 Data for Clym116 in Iga Nephropathy

THOMSON REUTERS

Climb Bio - Phase 2 Navigate-2 Trial Ongoing; Initial Data Expected H1 2027, Phase 3 Initiation in 2027

THOMSON REUTERS

Climb Bio - Clym116 Well-Tolerated with no Serious Adverse Events or Dose-Limiting Toxicities

THOMSON REUTERS

Invivyd Grants New-Hire Inducement Stock Options for 255,000 Shares at $0.88 Each

Invivyd Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

NeuroSense Therapeutics Initiated at Buy by HC Wainwright & Co.

Torrid Holdings (CURV) Receives a Hold from Telsey Advisory

Analysts Offer Insights on Technology Companies: Similarweb (SMWB) and UiPath (PATH)

TScan Therapeutics Cut to Hold from Buy by Needham

Onconic Therapeutics Independent Director Resigns After Public Appointment

Analysts Offer Insights on Technology Companies: Strategy (MSTR), Full Truck Alliance (YMM) and JFrog (FROG)

Nxera Pharma to Receive USD 8.6 Million Milestone Payment from Centessa

Cutia Therapeutics' Marketing Application for Botox Product Accepted in China

MT Newswires Live

Robinhood Chain Beats Tron in 24-Hour Revenue

TScan Therapeutics Inc : Needham Cuts to Hold from Buy

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/BK4539/news?page=31"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":693.02655,"timestamp":1789156799999,"preClose":688.91504,"halted":0,"volume":272157313,"delay":0,"changeRate":0.005968,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":4.111511,"latestTime":"09-11 16:00:00 EDT","open":689.8237,"high":698.2087,"low":685.0665,"amount":8901943117.280722,"amplitude":0.019077,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.322141,"peRate":139.801509,"turnoverRate":0.021443,"increases":71,"decrements":69,"flats":10,"marketCap":479852364396.5,"floatMarketCap":365120021896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":698.2087,"amplitude":0.019077,"preClose":688.91504,"low":685.0665,"pbRate":"5.322141","latestPrice":693.02655,"volume":272157313,"delay":0,"open":689.8237,"prevYearClose":881.5255,"prevWeekClose":725.2816,"prevMonthClose":701.0681,"prevQuarterClose":742.922,"fiveDayClose":733.4782,"twentyDayClose":682.8836,"sixtyDayClose":729.1859,"secType":"PLATE","market":"US","turnoverRate":0.021443,"peRate":139.801509,"marketCap":479852364396.5,"floatMarketCap":365120021896,"timestamp":1789156799999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":71,"down":69,"flat":14},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:31,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664877191","title":"Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877191","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877191?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436800,"startTime":"0","endTime":"0","summary":"BOSTON, Sept.  03, 2026 (GLOBE NEWSWIRE) -- Damora Therapeutics, Inc. (NASDAQ: DMRA) (“Damora”), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355814/0/en/damora-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","DMRA","BK4139","LENZ","LCLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664779048","title":"Biomea Fusion to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664779048","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664779048?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436800,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., Sept.  03, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Company” or “Company management”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announc","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355833/0/en/biomea-fusion-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BMEA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664136877","title":"Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664136877","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664136877?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436800,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., Sept.  03, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355844/0/en/grace-therapeutics-to-participate-in-the-h-c-wainright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","LABU","BK4539","BK4007","BK4585","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664871981","title":"Climb Bio Reports Early Phase 1 Data for IgA Nephropathy Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2664871981","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664871981?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:54","pubTimestamp":1788436486,"startTime":"0","endTime":"0","summary":"Climb Bio  said Thursday its phase 1 trial data for its experimental antibody treatment CLYM116 demonstrated a 29-day half-life that supports dosing every 12 weeks for patients with IgA nephropathy.A single 320-milligram dose achieved nearly complete protein suppression and lowered specific antibody levels by 60% to 75% over a 12-week period, the company said.The kidney disease drug candidate was generally well-tolerated without any serious adverse events or dose-limiting toxicities, it said.The company plans to release initial findings from an ongoing phase 2 trial during H1 of 2027, and to start a phase 3 study in 2027, Climb Bio said.Shares of the company were up 7% in Thursday premarket activity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4539","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664876603","title":"Clean Sweep or Split Congress, These are the Trades to Make on the Midterms Outcome, Says JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2664876603","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664876603?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:11","pubTimestamp":1788433869,"startTime":"0","endTime":"0","summary":"Some stocks face a vey different environment depending on how America votesThe battle in Texas between Democratic nominee James Talarico, left, and Republican candidate Ken Paxton could swing the U.S.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APED","LU0444971666.USD","BK4504","LU0963586101.USD","BK4600","BK4141","LU1201861249.SGD","TRUN","LU1244550221.USD","LU2471134952.CNY","LU0466842654.USD","BLCK","AVGW","IE00B7SZLL34.SGD","FENY","LNGX","LU0320765489.SGD","LU2111349929.HKD","LU1732800096.USD","LU0949170772.SGD","LU1814569148.SGD","LU2456880835.USD","LU2458330169.SGD","IE00BYXW3230.USD","FAI","LU0823414551.USD","SG9999015978.USD","LU0965508806.USD","LU0724617625.USD","LU0154236417.USD","HOYY","LU1791710582.SGD","LU2125154778.USD","XLF","LU0289961442.SGD","LU0109392836.USD","IE00BMG7P587.USD","UGE","ILIT","SPTE","IE00BQXX3C00.GBP","LU2360107325.USD","LU1934455277.USD","LU1732799900.SGD","WNTR","IE00BKPKM429.USD","BK4149","LU1691799644.USD","LU2279689827.SGD","LU0211331839.USD","IYF","LU1861558580.USD","LU0006061336.USD","LU1066051498.USD","UXI","LU2237443465.HKD","BK4596","LU0345769128.USD","LU0477156797.USD","LU1201861165.SGD","IE0034235188.USD","NULC","LU1035773651.USD","LU2092937221.SGD","LU2089985449.USD","MLPX","XLE","IE0004091025.USD","SG9999015952.SGD","IE0009356076.USD","MSTR","BK4094","COIA","LU0211326755.USD","LU0345780950.USD","LU0238689110.USD","LU2361045086.USD","LMT","LU2362541513.USD","IE00BLSP4452.SGD","PSCH","LU1868836757.USD","MLPI","LU0345769631.USD","HWAY","IE0001KFT4U8.USD","WMB","LU2999663052.SGD","LU0726765562.USD","LU1861220033.SGD","HK0000532082.HKD","LU2764263039.SGD","HOOI","LU0985320562.USD","LU0788109477.HKD","LU0251132253.USD","LU1670711040.USD","LU0006306889.USD","LU0061474705.USD","LU1037948541.HKD","LU0251142724.SGD","LU1868836914.USD","LU2750360641.GBP","09399","LU0354030438.USD","GB00BDT5M118.USD","BK4503","LU0057025933.USD","SG9999002224.SGD","LU2461242641.AUD","RSPG","LU1145028129.USD","LU2462591277.SGD","LU0444973449.USD","LU1162221912.USD","LU2720916845.USD","IE00BHPRN162.USD","LU2764262908.HKD","FCG","LU2360106780.USD","LU1935042991.SGD","BK4202","LU2462157665.USD","LIMI","LU2506952170.USD","AVAV","LU1066051225.USD","LU0149725797.USD","LU2211814178.USD","CNCG","BK4144","IE0004445015.USD","LU0957808578.USD","LU2764263203.CNY","GASZ","IE00B4JS1V06.HKD","LU0225283273.USD","LU1169590202.USD","LU1261432733.SGD","ROKT","LU2403377893.USD","ESLG","LULU","IE00BJJMRX11.SGD","IE00BD4GTW91.USD","LU1551013425.SGD","LU2360108059.USD","LU0949170426.SGD","BK4598","LU2023250843.SGD","LITP","LU0256863811.USD","LU0308772762.SGD","LU0417517546.SGD","IE00BFSS7M15.SGD","LU1670711123.USD","ROBN","BK4127","IE00BJLML261.HKD","LU0234572021.USD","IE000M9KFDE8.USD","LU1084165304.USD","LU1992135399.USD","RSHO","JPO","LU2065170008.USD","REMX","LU2433249047.HKD","LU0069063385.USD","LU0477156953.USD","MS","LU0708994859.HKD","HOOY","LU2087625088.SGD","IYG","LU1861214812.USD","IE00BD4GTV84.USD","LU2065169927.USD","LU0630314457.HKD","LU1032466523.USD","LU1037948897.HKD","IE00BZ1G4Q59.USD","LU2417539215.USD","IE000WXP2NQ0.USD","BK4023","DIPR","EMLP","IE00BGHQF524.EUR","IE00B19Z4B17.USD","IE00BMG7P702.HKD","IE00BMPRXQ63.HKD","LU0048584097.USD","LU0979878070.USD","LU1989763427.SGD","COIG","IE00BMCWC346.EUR","LU1868836591.USD","USD","OWNB","ROST","ALB","EVRDD","LU2041044095.USD","IE00BVYPNQ40.USD","LU2237443978.SGD","FOWF","LU0203201768.USD","LU0300736062.USD","SGXZ51526630.SGD","WMTI","LU0683600562.USD","LU2023250504.SGD","LU2362541273.HKD","LU0265550946.USD","LU0345770308.USD","LU1815333072.USD","07799","MSTY.UK","IE00BKVL7J92.USD","LU0784383803.USD","LU0106261372.USD","LU2089284900.SGD","LU0097036916.USD","ARTY","LU2264538146.SGD","LU2473716301.USD","AIFD","MSTW","HOOD","BK4550","LU2746668974.SGD","HOII","LU0127658192.USD","LU2552382215.SGD","BK4585","SAVGOmain","LU0557290698.USD","KMI","MSTK","BK4154","LU2168564495.EUR","CHPX","EVR","LU2552382058.USD","BK4207","LU1670627923.USD","XLK","09711","LU0048573561.USD","LU0511384066.AUD","LU0545039389.USD","SG9999014005.SGD","LU2506952097.USD","LU2298321311.HKD","IE00B66KJ199.SGD","LU0648000940.SGD","BK4588","SG9999002232.USD","FDIG","IE00B7SZL793.SGD","SNOY","TEK","EIPI","LU2362540622.SGD","09799","IE00B3S45H60.SGD","BK4548","IE00B19Z9P08.USD","IE00BN8TJ469.HKD","LU0353189763.USD","LU1064131342.USD","BK4575","LU0784385170.HKD","LU0072461881.USD","LU1934455194.USD","LU0130517989.USD","LU0553294199.USD","LU1720051017.SGD","WDGF","LU0823434740.USD","LU1366333091.USD","LU2168564222.USD","IXN","DAT","CNC","IE00B3PB1722.GBP","CLOU","LU2048586759.USD","DG","LU1232071149.USD","LIT","LU2272731600.USD","ZS","LU0648001328.SGD","LU0274383776.USD","LU1623119135.USD","IE00B894F039.SGD","LU1323610961.USD","LU1645745479.HKD","LU0316494557.USD","KTUP","LU2095319765.USD","LU0345768153.USD","DAPP","LU2272731782.SGD","LU0300736492.USD","LU1074936037.SGD","IE00BJTD4N35.SGD","WEEI","LU2471134796.USD","AVGO","LU1923622614.USD","IE00BMG7P694.USD","LU1670710588.SGD","LU1003077747.HKD","LU0689472784.USD","IE00B7KXQ091.USD","LU1720051108.HKD","IE00BVYPNV92.GBP","LU0964807845.USD","IE0031619046.USD","IE00BMG7P926.USD","MSTC","BK4533","MSII","LU0082616367.USD","LU0203345920.USD","LU2213496289.HKD","LU2133065610.SGD","LU0143551892.USD","LU2506951958.HKD","GSX","LU1861219969.SGD","LU2294711713.HKD","LU0965509010.AUD","LU2210150020.SGD","LU1791710400.SGD","LU2265009873.SGD","LU2237443622.USD","HOOC","LU1585245621.USD","LU2089283258.USD","MSTP","FSTA","LU0390134368.USD","BK4114","LU0738911758.USD","MTYY","LU0757428866.USD","IE0034235295.USD","IE00BSNM7G36.USD","MSOO","IE00BQXX3F31.USD","BK4535","IE00BFXG1179.USD","LU1621768115.EUR","HK0000914660.USD","LU0314104364.USD","BK4505","LU1989764748.USD","LU1935043536.SGD","VFH","CONX","LU0345770993.USD","LU2250418816.HKD","LU1852331112.SGD","LU2487616109.SGD","LU1066053197.SGD","CONY","LU0096362180.USD","LU0210536198.USD","SG9999001440.SGD","LU1291159041.SGD","LU2750360997.AUD","IDEF","LU0211327993.USD","LU0256863902.USD","LU0971096721.USD","HK0000914686.HKD","POWR","LU2360107168.USD","RTH","WMT","CGDG","LU0868494708.USD","RTX","LU1951200564.SGD","LU2505996681.GBP","BK4528","IE00BN29S564.USD","LU0266512473.USD","SG9999015945.SGD","MOH","LU2506951792.HKD","LU0708995401.HKD","CGBL","MPG","LU0689626769.HKD","LU0080751232.USD","LU0094547139.USD","IETC","LU0823414478.USD","LU1629891620.HKD","FINX","MRCY","LU0368265418.SGD","LU1815336091.USD","NVIR","LU1280957306.USD","SGXZ99366536.SGD","LU1917777945.USD","SG9999002521.SGD","BK4554","UYG","IE00BJJMRY28.SGD","BK4516","BK4109","JPMO","BK4597","LU0784385840.USD","SG9999014021.USD","LU0472753341.HKD","BK4155","BK4097","REXC","LU1674673428.USD","LU0672654240.SGD","LU0348723411.USD","LU1242518931.SGD","MSST","BK4613","LU0081259029.USD","TNGY","LU1878469433.USD","LU1670628061.USD","LU0823411888.USD","BK4547","XLP","LU2272731865.HKD","IE00BD6J9T35.USD","LU2247934214.USD","IE0005OL40V9.USD","TRUF","TRUO","LU1974910355.USD","LU1778281490.HKD","IE00BLSP4239.USD","SHLD","LU0203202063.USD","IE00B19Z9Z06.USD","LU2430703095.HKD","LU2463028550.USD","SMST","IVEP","LU2471134879.HKD","SGXZ81514606.USD","GS","LU1923623000.USD","IE00B19Z3B42.SGD","LU0061474960.USD","LU0158827781.USD","BK4112","SOXQ","IE00BMG7P819.SGD","AVGG","BK4564","LU1929549753.HKD","LU2860962120.EUR","LU2746668461.USD","SOXX","THC","VDE","LU1989772840.SGD","DOCU","LU0130518102.USD","COII","BK4605","IE00BK4W5M84.HKD","LU2324357040.USD","TTXU","LU1035775433.USD","LU1815336760.USD","CGGO","LU0795875169.SGD","LU1548497426.USD","IE00BKDWB100.SGD","TEXU","LU2506951875.HKD","LU1868837300.USD","LU1621768206.USD","LU2063271972.USD","LULG","LU1914381329.SGD","LU0980610538.SGD","LU0124676726.USD","LU2290526834.HKD","LU2097829019.USD","LU2023251221.USD","LU2249611893.SGD","3LMI.UK","BITQ","LU0070217475.USD","LU0251131958.USD","FTEC","IE00BMPRXN33.USD","SETM","LU0170899867.USD","LU0320765646.SGD","BK4552","LU0289739343.SGD","LU0965509101.SGD","LU1861220207.SGD","AVXX","CIBR","LU2896262040.SGD","LU2552382132.HKD","LU0889565833.HKD","IE00BDGV0183.EUR","LU1267930730.SGD","HK0000819398.USD","IE00BD4GTT62.SGD","LU1803068623.USD","SNOU","MST","BK4168","LU0079474960.USD","LU0130103400.USD","LU0070302665.USD","LU0267386448.USD","LU0642271901.SGD","LU1144417596.USD","AVL","LU0106831901.USD","LU1069347547.HKD","SG9999003800.SGD","CONI","BK4604","LU0210528500.USD","LU1119994496.HKD","LU1979441026.SGD","SG9999004303.SGD","IE00B775H168.HKD","LU0528227936.USD","SGXZ23171101.USD","LU0122376428.USD","IE00BBT3K403.USD","09311","IE00B2Q91V27.USD","LU1366192091.USD","LU1670756490.USD","LU0784384876.USD","NATO","DIG","IE00BK4W5L77.USD","LU0266512127.USD","IE000SL1IH01.SGD","LU0505663152.USD","IE00B19Z3581.USD","LU0162691827.USD","LU0861579265.USD","LU1496350502.SGD","LU1894683264.USD","LU2125909759.SGD","LU0198837287.USD","HOOG","COIN","LU1791807156.HKD","BK4551","LU1712237335.SGD","LU0859254822.USD","LU1267930490.SGD","LU0128525929.USD","LU1316542783.SGD","LU0820562030.AUD","LU0965509283.SGD","LU1116320737.USD","LU1935043023.USD","FIAT","LU0011850046.USD","LU1400636491.USD","07711","LU0943347566.SGD","LU1861217088.USD","LU1989764664.SGD","LU0345781412.USD","FNCL","LU2083900584.USD","HODU","LU1069344957.HKD","IE000HOSIQF4.USD","GXPE","AVS","LU0109391861.USD","KBWB","LU1668664300.SGD","LU1894683348.USD","TTEQ","MSDD","SMI3.UK","LU1363072403.SGD","LU1621767737.EUR","JGRO","LU0353189680.USD","IE00B775SV38.USD","LU0942090050.USD","LU2543165471.USD","LU2381873111.SGD","LU0823417737.USD","LU2211815571.USD","LU2505996509.AUD","IE0002270589.USD","BK4116","LU1496350171.SGD","IXG","LU1400636574.HKD","BK4559","BK4185","LU0323240290.USD","LU2430703251.USD","LU0072462426.USD","LU2347655156.SGD","TRUI","LU0788109394.HKD","LU0174119429.USD","LU0456854461.SGD","COIX","LU1699723380.USD","EXI","LU0096364046.USD","LU1988902786.USD","LU2237438978.USD","XDAT","IE00BGHQDM52.EUR","BK4566","LU0912757837.SGD","LU2931357623.SGD","MSTU","ALBG","SG9999001424.SGD","USXF","LU2360032135.SGD","IE00BZ9MQY76.HKD","LMTL","USAI","3SMI.UK","SHOC","ICOI","LU0640476718.USD","LU2242650005.HKD","IEO","LU1861559042.SGD","BK4612","TDIV","TRFK","LU1242518857.USD","LU2237443549.SGD","LU2237957902.USD","LU0211326839.USD","LU1718418525.SGD","LU0496365809.HKD","BAI","LU0882574139.USD","LU2125909916.SGD","IE0034235303.USD","HOOZ","LU1804176565.USD","LU2592432038.USD","IE00BWXC8680.SGD","BK4607","LU2954938101.SGD","BK4595","LU2357627491.SGD","LU0823434583.USD","LU2637965513.SGD","SMHX","IMST","LU2355687059.USD","LU2322448791.USD","LU2756315318.SGD","BK4603","COIW","RTXG","LU0234570918.USD","IE00B3CCJ963.GBP","LU2108987350.USD","BKCH","LU2430703178.SGD","LU0787776722.HKD","BK4543","PPA","IAI","LMI3.UK","LU2462591350.SGD","IYE","LU0265550359.USD","IE00BGHQF631.EUR","IE00BJTD4V19.USD","IE00BFSS8Q28.SGD","LU0786609619.USD","UMI","WISE","LU2384288077.EUR","BK4539","LU2054465674.USD","TFNS","CATG","IBLC","LU2271345857.HKD","TPYP","GD","LU1621767810.EUR","LU0203347892.USD","LU0795875086.SGD","BK4187","LU2420271590.USD","LU2458330243.SGD","LU1244550494.USD","BK4515","LU2286300806.USD","CHAT","LU2463526074.USD","MSTZ","LU1935042488.USD","LU0820561818.USD","MSTX","LU2357125470.USD","HOOX","LU2125909593.SGD","VGT","AVGU","LU2360107671.USD","LU2106854487.HKD","IE00BMPRXR70.SGD","LU2471134523.USD","LU2065171311.SGD","BK4512","LU2361044949.HKD","LU2237957811.SGD","KTOS","MPL","HAKY","SG9999000418.SGD","LU1430594728.SGD","COYY","SG9999011175.SGD","LU1400636657.SGD","LU2028103732.USD","LU1116320901.HKD","EQT","LU1301847155.USD","LU0345768740.USD","LU1951198990.SGD","LMTS","SG9999015986.USD","CRPT","LU1989772923.USD","IE0004445239.USD","LU1202635105.USD","LU0029864427.USD","LU0210533765.USD","IE00BVYPNW00.USD","LU0133085943.USD","LU1551013342.USD","LU1861215975.USD","LU2023250330.USD","IE00BVYPNP33.GBP","LU1153585028.USD","LU1992135472.HKD","SNOW","MP","AVGC","LU1670710661.SGD","LU2361044865.SGD","LU0053666078.USD","MADE","LU0187121727.USD","LU1868837136.USD","LU2125154935.USD","LU0310799852.SGD","SG9999014013.SGD","BK4560","IE00B42XCP33.USD","IE00BDRTCR15.USD","DRNZ","LU2168564149.EUR","TPZ","USNG","IE00BYV24P56.USD","LU1066051811.HKD","FTXO","07311","LU0310800379.SGD","HOOW","IE0004086264.USD","LU0950375773.USD","LU2602419157.SGD","MDST","PXE","LU0266013472.USD","LU1923622291.USD","LU2236285917.USD","AVGX","LU1244550577.SGD","LU0354030511.USD","LU2168564065.EUR","LU0719512351.SGD","IE00B5949003.HKD","BK4532","ENFR","BESF","LU2210149790.SGD","LU2756315664.SGD","IE00B1BXHZ80.USD","BK4581","COIO","LU1803068979.SGD","LU0289960550.SGD","ITA","LU0157215616.USD","07399","BPAY","BZZ","LU2242649171.HKD","LU0158827948.USD","LU0056508442.USD","THMR","LU0320765059.SGD","LU0820561909.HKD","LU1267930573.SGD","CAT","BK4520","LU0098860793.USD","LU1642822529.SGD","LU0211328371.USD","LU1169589451.USD","LU2065171402.SGD","LU0061475181.USD","LU0323591593.USD","DFEN","LU0130102774.USD","LU0976567544.SGD","LU2322448957.HKD","BK4545","LU2168563687.JPY","LU0215105999.USD","JPM","LU2237443895.HKD","LU1989771016.USD","LU0276348264.USD","LU1989763690.USD","IE00B1XK9C88.USD","MSTY","LU2357305700.SGD","LU1127390331.HKD","LU0661504455.SGD","LU0742534661.SGD","LU2125909247.SGD","LU2244417387.USD","LU0868494617.USD","LU1935042215.USD","SG9999014039.USD","LU0208291251.USD","BK4534","LU2347655073.USD","LU0823417653.USD","LU0175139822.USD","LU2237443382.USD","LU1934455863.HKD","BK4213","LU0957791311.USD","MISL","LU0476273544.USD","LU0323239441.USD","IE00BDCRKT87.USD","LU1674673691.USD","EINC","CONL","IE00BQXX3D17.EUR","IDRV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664760688","title":"Climb Bio - Announces Positive Phase 1 Data for Clym116 in Iga Nephropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664760688","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664760688?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:03","pubTimestamp":1788433403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44U1DM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLYM","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664087606","title":"Climb Bio - Phase 2 Navigate-2 Trial Ongoing; Initial Data Expected H1 2027, Phase 3 Initiation in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664087606","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664087606?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:03","pubTimestamp":1788433403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44U1DM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLYM","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664065876","title":"Climb Bio - Clym116 Well-Tolerated with no Serious Adverse Events or Dose-Limiting Toxicities","url":"https://stock-news.laohu8.com/highlight/detail?id=2664065876","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664065876?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:03","pubTimestamp":1788433403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44U1DM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CLYM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664876042","title":"Invivyd Grants New-Hire Inducement Stock Options for 255,000 Shares at $0.88 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2664876042","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664876042?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:02","pubTimestamp":1788433364,"startTime":"0","endTime":"0","summary":"Invivyd grants new-hire inducement stock options for 255,000 shares at $0.88 eachInvivyd granted stock options for 255,000 shares to six newly hired non-executive employees on Sept. 1, 2026.Exercise p","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL1k2KpD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BQXX3C00.GBP","SG9999014013.SGD","IE00BKPKM429.USD","IVVD","LU2210149790.SGD","LU0314104364.USD","IE00B64PRP62.GBP","BCDF","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00BQXX3F31.USD","BK4112","IE00BN0W2T93.GBP","BK4539","SG9999014039.USD","SG9999014005.SGD","SG9999014021.USD","IE00BN0W2V16.EUR","BK4585","IE00BQXX3D17.EUR","BK4139","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4588","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664795876","title":"Invivyd Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664795876","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664795876?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:01","pubTimestamp":1788433260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA4GVNGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IVVD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664487503","title":"NeuroSense Therapeutics Initiated at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2664487503","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664487503?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:28","pubTimestamp":1788431280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NRSN/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","NRSN","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664034873","title":"Torrid Holdings (CURV) Receives a Hold from Telsey Advisory","url":"https://stock-news.laohu8.com/highlight/detail?id=2664034873","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664034873?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:55","pubTimestamp":1788429316,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Dana Telsey from Telsey Advisory maintained a Hold rating on Torrid Holdings, with a price target of $2.00. The com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/torrid-holdings-curv-receives-a-hold-from-telsey-advisory-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/torrid-holdings-curv-receives-a-hold-from-telsey-advisory-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4094","CURV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664873567","title":"Analysts Offer Insights on Technology Companies: Similarweb (SMWB) and UiPath (PATH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664873567","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664873567?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:30","pubTimestamp":1788427810,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Technology sector with new ratings on Similarweb (SMWB) and UiPath (PATH). Similarweb (SMWB) William Bl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-similarweb-smwb-and-uipath-path-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-similarweb-smwb-and-uipath-path-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4543","TECS","LU1861559042.SGD","BK4023","BK4539","BK4551","SMWB","BK4561","BK4547","BK4585","BK4505","BK4604","LU1861558580.USD","PATH","ARTY","BK4097","PATX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878642","title":"TScan Therapeutics Cut to Hold from Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878642","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664878642?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:16","pubTimestamp":1788426960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TCRX/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TCRX","LENZ","BK4007","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878955","title":"Onconic Therapeutics Independent Director Resigns After Public Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878955","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664878955?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:15","pubTimestamp":1788426905,"startTime":"0","endTime":"0","summary":"Onconic Therapeutics, Inc. ( ($KR:476060) ) has issued an announcement. Onconic Therapeutics has reported the mid-term resignation of independent d...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/onconic-therapeutics-independent-director-resigns-after-public-appointment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/onconic-therapeutics-independent-director-resigns-after-public-appointment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664205658","title":"Analysts Offer Insights on Technology Companies: Strategy (MSTR), Full Truck Alliance (YMM) and JFrog (FROG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664205658","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664205658?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:30","pubTimestamp":1788424222,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Strategy (MSTR), Full Truck Alliance (YMM) and JFrog...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-strategy-mstr-full-truck-alliance-ymm-and-jfrog-frog-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-strategy-mstr-full-truck-alliance-ymm-and-jfrog-frog-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["YMM","SMI3.UK","LU0566484027.USD","MSTW","LU2247934214.USD","BITQ","MSTP","APED","BK4097","BK4585","BK4596","LU0359201612.USD","BK4232","BK4503","LU0251143458.SGD","MSTX","LU0154245673.USD","LU2125909759.SGD","LU0049112450.USD","LU0154245756.USD","LU0053671581.USD","MTYY","MSTC","LU0327786744.USD","07799","LU1559883803.SGD","LU0359201885.HKD","OWNB","07399","LU0502904849.HKD","LU1023057109.AUD","MSTK","LU2125909916.SGD","MST","MSII","MSTU","WCLD","IE00B12V2V27.USD","LU1046422090.SGD","WNTR","LU2242644610.SGD","09799","CRPT","3LMI.UK","BK4588","LU0261950470.USD","BK4022","SMST","LU1235295612.USD","BK4539","3SMI.UK","BK4516","MSTR","09399","LMI3.UK","MSOO","LU0572944931.SGD","LU0359202008.SGD","MSDD","LU0456842615.SGD","BK4595","IE00BYTNYN87.SGD","IMST","BK4548","MSST","BK4600","LU0455707207.USD","LU0048575426.USD","MSTY","MSTY.UK","BK4023","IE00BYQNZ168.SGD","BK4526","LU1923622291.USD","MSTZ","SG9999011746.SGD","FROG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664821280","title":"Nxera Pharma to Receive USD 8.6 Million Milestone Payment from Centessa","url":"https://stock-news.laohu8.com/highlight/detail?id=2664821280","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664821280?lang=en_us&edition=fundamental","pubTime":"2026-09-03 14:34","pubTimestamp":1788417272,"startTime":"0","endTime":"0","summary":"Nxera Pharma to receive USD 8.6 million milestone payment from CentessaNxera Pharma will receive a USD 8.6 million milestone payment from Centessa tied to late-stage development progress in its OX2R a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL5VG1WF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTA","BK4139","BK4007","BK4539","SOLTF","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664257448","title":"Cutia Therapeutics' Marketing Application for Botox Product Accepted in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2664257448","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664257448?lang=en_us&edition=fundamental","pubTime":"2026-09-03 12:03","pubTimestamp":1788408198,"startTime":"0","endTime":"0","summary":"Cutia Therapeutics (HKG:2487) said its biologics license application for CU-20101, or botulinum toxin type A, has been accepted by China's medical products regulator, according to a Thursday filing.The indication is for improving moderate-to-severe glabellar lines, the filing said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","LENZ","02487","BK4139","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664879633","title":"Robinhood Chain Beats Tron in 24-Hour Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2664879633","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664879633?lang=en_us&edition=fundamental","pubTime":"2026-09-03 12:01","pubTimestamp":1788408060,"startTime":"0","endTime":"0","summary":"Barely a few months after it launched, Robinhood Chain has continued to outperform major blockchains in several network activities as it continues to gain traction across the global space.Following it","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"utodaynews_highlight","url":"https://u.today/robinhood-chain-beats-tron-in-24-hour-revenue","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/robinhood-chain-beats-tron-in-24-hour-revenue","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["HOII","BLCK","HODU","FINX","BK4539","BK4127","HOOZ","HOOX","HOOG","HOOW","TRON","CRPT","ROBN","HOOI","BK4190","HOOC","HOOD","IAI","LU1861559042.SGD","HOOY","BPAY","HOYY","BK4547","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664882397","title":"TScan Therapeutics Inc : Needham Cuts to Hold from Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664882397","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664882397?lang=en_us&edition=fundamental","pubTime":"2026-09-03 10:50","pubTimestamp":1788403819,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44U0TA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","TCRX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":45,"pageCount":31,"totalSize":897,"code":"91000000","status":"200"}]}}